LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
LEMAITRE VASCULAR INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$82.31+1.49 (+1.84%)
Close on Oct 19, 2026
- Market cap
- $2.02B
- P/E (TTM)
- 28.9
- Dividend yield
- 0.97%
LEMAITRE VASCULAR INC revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $38.25M | $37.19M | $35.70M | $34.59M | $36.66M | $34.63M | $32.93M | $31.89M | $32.80M | $31.13M | $29.68M | $28.80M | 54.3% | +4.3% |
| Other countries | $18.52M | $16.65M | $16.60M | $14.81M | $15.87M | $14.40M | $13.31M | $12.87M | $13.21M | $12.70M | $10.73M | $10.68M | 26.3% | +16.7% |
| Germany | $5.34M | $5.54M | $4.98M | $4.48M | $4.46M | $3.98M | $3.50M | $3.89M | $3.51M | $3.52M | $3.17M | $3.32M | 7.6% | +19.8% |
| Canada | $4.55M | $4.05M | $3.74M | $3.83M | $3.96M | $3.72M | $3.10M | $3.34M | $3.62M | $3.61M | $2.69M | $2.62M | 6.5% | +15.1% |
| United Kingdom | $3.73M | $3.13M | $3.44M | $3.34M | $3.30M | $3.15M | $2.88M | $2.83M | $2.72M | $2.53M | $2.61M | $2.00M | 5.3% | +13.0% |
| Americas | – | – | – | – | – | – | $36.63M | $35.80M | $36.91M | $35.25M | $32.81M | $31.86M | – | – |
| Asia Pacific | – | – | – | – | – | – | $3.81M | $4.02M | $3.64M | $3.84M | $3.15M | $3.23M | – | – |
| Europe, Middle East and Africa | – | – | – | – | – | – | $15.28M | $15.00M | $15.30M | $14.40M | $12.92M | $12.32M | – | – |
From the segment and revenue-disaggregation notes of Lemaitre Vascular's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.